Denali Therapeutics Inc (DNLI)

Deferred Revenue

$0.00

Quarterly · Period ending: · USD

DNLI logo

DNLI Deferred Revenue

Latest reported$0.00
DNLI Quarterly Deferred Revenue ($0.00 → $0.00)
High-resolution chart · PNG

DNLI deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
0
15,116,000
0
22,580,000
0
0
0
0
0
0
0
0
845,000
289,757,000
290,053,000
290,539,000
0
290,627,000
320,301,000
0
9,193,000
0
23,483,000
72,869,000
34,134,000
24,674,000
18,739,000
18,185,000
22,598,000
23,148,000
11,427,000
12,658,000
8,715,000
8,434,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.